chartexchange

HLS Therapeutics Inc (HLTRF) (Q3 2026) Earnings Call Highlights: Cardiovascular Surge Offsets ...

GuruFocus | Nov 12, 2026 8:04 PM EST

HLS Therapeutics Inc (HLTRF) posted 5% revenue growth to $14.2 million as its cardiovascular portfolio climbed 21%, Nilemdo patient starts accelerated, and debt fell 17%, though adjusted EBITDA… Related Stocks: HLTRF ,

Read original article